Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand
Aim To determine factors associated with severe hospitalized Respiratory syncytial virus (RSV)‐associated LRTI and to describe management in tertiary care center. Methods Retrospective medical record review was conducted among children under 5 years old hospitalized with RSV‐associated LRTI at King...
Gespeichert in:
| Veröffentlicht in: | Influenza and other respiratory viruses 2021-01, Vol.15 (1), p.64-71 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 71 |
|---|---|
| container_issue | 1 |
| container_start_page | 64 |
| container_title | Influenza and other respiratory viruses |
| container_volume | 15 |
| creator | Aikphaibul, Puneyavee Theerawit, Tuangtip Sophonphan, Jiratchaya Wacharachaisurapol, Noppadol Jitrungruengnij, Nattapong Puthanakit, Thanyawee |
| description | Aim
To determine factors associated with severe hospitalized Respiratory syncytial virus (RSV)‐associated LRTI and to describe management in tertiary care center.
Methods
Retrospective medical record review was conducted among children under 5 years old hospitalized with RSV‐associated LRTI at King Chulalongkorn Memorial Hospital. Severe RSV‐associated LRTI was defined as death, mechanical ventilator, or positive pressure ventilation use, prolonged hospitalization >7 days. Factors associated with severe RSV were analyzed using univariate and multivariate logistic regression.
Results
From January 2011 to December 2016, 427 children were hospitalized. Median age was 10 months (IQR 4.2‐23.0). One hundred seventy‐four (41%) patients had severe RSV (11 deaths, 56 mechanical ventilators, 19 positive pressure ventilation, and 88 prolonged hospitalization). Factors associated with severe RSV were chronic lung disease (aOR 15.16 [4.26‐53.91]), cirrhosis/biliary atresia (aOR 15.01 [3.21‐70.32]), congenital heart disease (aOR 5.11 [1.97‐13.23]), chemotherapy (aOR 4.7 [1.34‐16.56]), and pre‐term (aOR 2.03 [1.13‐3.67]). Oxygen therapy was mainly low flow oxygen delivery. 88% of cases received bronchodilator. Parenteral antibiotics were prescribed in 37.9% of cases.
Conclusions
Children with co‐morbidities have higher risk of severe RSV‐associated LRTI. More than two‐third of patients received bronchodilator, of which was not recommended by American Academy of Pediatrics. The specific treatment and prevention for RSV are urgently needed. |
| doi_str_mv | 10.1111/irv.12793 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7767956</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A711798055</galeid><sourcerecordid>A711798055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5103-2b5b8a6c67f50e2ba94bee80ca97735dcd44b860206b6ed431a76126a65b5ee73</originalsourceid><addsrcrecordid>eNp1kU1vEzEQhi1ERUvhwB9Aljj1kNTf3r0gVRWFSpWQqsLV8npnG5fddbA3Qemv74SUQKViHzweP_P6tYeQd5zNOY7TmNdzLmwtX5AjbjWbCaPrl_tYsUPyupQ7xrSptHpFDqWwlZQVOyLDdSw_aOfDlHKhqaMF1pCBLlJZxsn38R5amgE32SOyoWUzhs0UfU_XMa8KjWMHYYppxIhOkPEIqeBRI8CIiW3-ZuFj78f2DTnofF_g7eN6TL5dfLo5_zK7-vr58vzsahY0Z3ImGt1U3gRjO81ANL5WDUDFgq-tlboNrVJNZZhgpjHQKsm9NVwYb3SjAaw8Jh93ustVM0C7NZJ975Y5DujOJR_d05MxLtxtWjtrja21QYEPjwI5_VxBmdxdWuURPTuhrKiV0rL-S936Hhz-REKxMMQS3Jnl3NYV0xqp-TMUzhaGGNIIXcT8k4KTXUHIqZQM3d44Z27bcIcNd78bjuz7f1-6J_90GIHTHfALb9n8X8ldXn_fST4AJFS22A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2472944539</pqid></control><display><type>article</type><title>Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand</title><source>DOAJ Directory of Open Access Journals</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Aikphaibul, Puneyavee ; Theerawit, Tuangtip ; Sophonphan, Jiratchaya ; Wacharachaisurapol, Noppadol ; Jitrungruengnij, Nattapong ; Puthanakit, Thanyawee</creator><creatorcontrib>Aikphaibul, Puneyavee ; Theerawit, Tuangtip ; Sophonphan, Jiratchaya ; Wacharachaisurapol, Noppadol ; Jitrungruengnij, Nattapong ; Puthanakit, Thanyawee</creatorcontrib><description>Aim
To determine factors associated with severe hospitalized Respiratory syncytial virus (RSV)‐associated LRTI and to describe management in tertiary care center.
Methods
Retrospective medical record review was conducted among children under 5 years old hospitalized with RSV‐associated LRTI at King Chulalongkorn Memorial Hospital. Severe RSV‐associated LRTI was defined as death, mechanical ventilator, or positive pressure ventilation use, prolonged hospitalization >7 days. Factors associated with severe RSV were analyzed using univariate and multivariate logistic regression.
Results
From January 2011 to December 2016, 427 children were hospitalized. Median age was 10 months (IQR 4.2‐23.0). One hundred seventy‐four (41%) patients had severe RSV (11 deaths, 56 mechanical ventilators, 19 positive pressure ventilation, and 88 prolonged hospitalization). Factors associated with severe RSV were chronic lung disease (aOR 15.16 [4.26‐53.91]), cirrhosis/biliary atresia (aOR 15.01 [3.21‐70.32]), congenital heart disease (aOR 5.11 [1.97‐13.23]), chemotherapy (aOR 4.7 [1.34‐16.56]), and pre‐term (aOR 2.03 [1.13‐3.67]). Oxygen therapy was mainly low flow oxygen delivery. 88% of cases received bronchodilator. Parenteral antibiotics were prescribed in 37.9% of cases.
Conclusions
Children with co‐morbidities have higher risk of severe RSV‐associated LRTI. More than two‐third of patients received bronchodilator, of which was not recommended by American Academy of Pediatrics. The specific treatment and prevention for RSV are urgently needed.</description><identifier>ISSN: 1750-2640</identifier><identifier>EISSN: 1750-2659</identifier><identifier>DOI: 10.1111/irv.12793</identifier><identifier>PMID: 32783380</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Antibiotics ; Antigens ; Biliary atresia ; bronchodilator ; Bronchodilators ; Cancer ; Cardiovascular disease ; Cardiovascular diseases ; Chemotherapy ; Children ; Cirrhosis ; community acquired ; Congenital diseases ; Congenital heart disease ; Convulsions & seizures ; Coronary artery disease ; death ; Developing countries ; Dyspnea ; Fever ; Genetic disorders ; Gestational age ; Health aspects ; Heart ; Heart diseases ; HIV ; Hospitalization ; Hospitals ; Human immunodeficiency virus ; Intubation ; Laboratories ; LDCs ; Liver cirrhosis ; Low flow ; Lung diseases ; Mechanical ventilation ; Medical records ; Morbidity ; Mortality ; nosocomial infection ; Nosocomial infections ; Original ; Oxygen ; Oxygen therapy ; Palivizumab ; Patients ; Pediatrics ; Regression analysis ; Respiratory diseases ; Respiratory syncytial virus ; Risk analysis ; Risk factors ; Ventilation ; Ventilators ; Virus diseases ; Viruses</subject><ispartof>Influenza and other respiratory viruses, 2021-01, Vol.15 (1), p.64-71</ispartof><rights>2020 The Authors. published by John Wiley & Sons Ltd</rights><rights>2020 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.</rights><rights>COPYRIGHT 2020 John Wiley & Sons, Inc.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5103-2b5b8a6c67f50e2ba94bee80ca97735dcd44b860206b6ed431a76126a65b5ee73</citedby><cites>FETCH-LOGICAL-c5103-2b5b8a6c67f50e2ba94bee80ca97735dcd44b860206b6ed431a76126a65b5ee73</cites><orcidid>0000-0002-5199-3749</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767956/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767956/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32783380$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aikphaibul, Puneyavee</creatorcontrib><creatorcontrib>Theerawit, Tuangtip</creatorcontrib><creatorcontrib>Sophonphan, Jiratchaya</creatorcontrib><creatorcontrib>Wacharachaisurapol, Noppadol</creatorcontrib><creatorcontrib>Jitrungruengnij, Nattapong</creatorcontrib><creatorcontrib>Puthanakit, Thanyawee</creatorcontrib><title>Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand</title><title>Influenza and other respiratory viruses</title><addtitle>Influenza Other Respir Viruses</addtitle><description>Aim
To determine factors associated with severe hospitalized Respiratory syncytial virus (RSV)‐associated LRTI and to describe management in tertiary care center.
Methods
Retrospective medical record review was conducted among children under 5 years old hospitalized with RSV‐associated LRTI at King Chulalongkorn Memorial Hospital. Severe RSV‐associated LRTI was defined as death, mechanical ventilator, or positive pressure ventilation use, prolonged hospitalization >7 days. Factors associated with severe RSV were analyzed using univariate and multivariate logistic regression.
Results
From January 2011 to December 2016, 427 children were hospitalized. Median age was 10 months (IQR 4.2‐23.0). One hundred seventy‐four (41%) patients had severe RSV (11 deaths, 56 mechanical ventilators, 19 positive pressure ventilation, and 88 prolonged hospitalization). Factors associated with severe RSV were chronic lung disease (aOR 15.16 [4.26‐53.91]), cirrhosis/biliary atresia (aOR 15.01 [3.21‐70.32]), congenital heart disease (aOR 5.11 [1.97‐13.23]), chemotherapy (aOR 4.7 [1.34‐16.56]), and pre‐term (aOR 2.03 [1.13‐3.67]). Oxygen therapy was mainly low flow oxygen delivery. 88% of cases received bronchodilator. Parenteral antibiotics were prescribed in 37.9% of cases.
Conclusions
Children with co‐morbidities have higher risk of severe RSV‐associated LRTI. More than two‐third of patients received bronchodilator, of which was not recommended by American Academy of Pediatrics. The specific treatment and prevention for RSV are urgently needed.</description><subject>Antibiotics</subject><subject>Antigens</subject><subject>Biliary atresia</subject><subject>bronchodilator</subject><subject>Bronchodilators</subject><subject>Cancer</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Chemotherapy</subject><subject>Children</subject><subject>Cirrhosis</subject><subject>community acquired</subject><subject>Congenital diseases</subject><subject>Congenital heart disease</subject><subject>Convulsions & seizures</subject><subject>Coronary artery disease</subject><subject>death</subject><subject>Developing countries</subject><subject>Dyspnea</subject><subject>Fever</subject><subject>Genetic disorders</subject><subject>Gestational age</subject><subject>Health aspects</subject><subject>Heart</subject><subject>Heart diseases</subject><subject>HIV</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Intubation</subject><subject>Laboratories</subject><subject>LDCs</subject><subject>Liver cirrhosis</subject><subject>Low flow</subject><subject>Lung diseases</subject><subject>Mechanical ventilation</subject><subject>Medical records</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>nosocomial infection</subject><subject>Nosocomial infections</subject><subject>Original</subject><subject>Oxygen</subject><subject>Oxygen therapy</subject><subject>Palivizumab</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Regression analysis</subject><subject>Respiratory diseases</subject><subject>Respiratory syncytial virus</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Ventilation</subject><subject>Ventilators</subject><subject>Virus diseases</subject><subject>Viruses</subject><issn>1750-2640</issn><issn>1750-2659</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1kU1vEzEQhi1ERUvhwB9Aljj1kNTf3r0gVRWFSpWQqsLV8npnG5fddbA3Qemv74SUQKViHzweP_P6tYeQd5zNOY7TmNdzLmwtX5AjbjWbCaPrl_tYsUPyupQ7xrSptHpFDqWwlZQVOyLDdSw_aOfDlHKhqaMF1pCBLlJZxsn38R5amgE32SOyoWUzhs0UfU_XMa8KjWMHYYppxIhOkPEIqeBRI8CIiW3-ZuFj78f2DTnofF_g7eN6TL5dfLo5_zK7-vr58vzsahY0Z3ImGt1U3gRjO81ANL5WDUDFgq-tlboNrVJNZZhgpjHQKsm9NVwYb3SjAaw8Jh93ustVM0C7NZJ975Y5DujOJR_d05MxLtxtWjtrja21QYEPjwI5_VxBmdxdWuURPTuhrKiV0rL-S936Hhz-REKxMMQS3Jnl3NYV0xqp-TMUzhaGGNIIXcT8k4KTXUHIqZQM3d44Z27bcIcNd78bjuz7f1-6J_90GIHTHfALb9n8X8ldXn_fST4AJFS22A</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Aikphaibul, Puneyavee</creator><creator>Theerawit, Tuangtip</creator><creator>Sophonphan, Jiratchaya</creator><creator>Wacharachaisurapol, Noppadol</creator><creator>Jitrungruengnij, Nattapong</creator><creator>Puthanakit, Thanyawee</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5199-3749</orcidid></search><sort><creationdate>202101</creationdate><title>Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand</title><author>Aikphaibul, Puneyavee ; Theerawit, Tuangtip ; Sophonphan, Jiratchaya ; Wacharachaisurapol, Noppadol ; Jitrungruengnij, Nattapong ; Puthanakit, Thanyawee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5103-2b5b8a6c67f50e2ba94bee80ca97735dcd44b860206b6ed431a76126a65b5ee73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibiotics</topic><topic>Antigens</topic><topic>Biliary atresia</topic><topic>bronchodilator</topic><topic>Bronchodilators</topic><topic>Cancer</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Chemotherapy</topic><topic>Children</topic><topic>Cirrhosis</topic><topic>community acquired</topic><topic>Congenital diseases</topic><topic>Congenital heart disease</topic><topic>Convulsions & seizures</topic><topic>Coronary artery disease</topic><topic>death</topic><topic>Developing countries</topic><topic>Dyspnea</topic><topic>Fever</topic><topic>Genetic disorders</topic><topic>Gestational age</topic><topic>Health aspects</topic><topic>Heart</topic><topic>Heart diseases</topic><topic>HIV</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Intubation</topic><topic>Laboratories</topic><topic>LDCs</topic><topic>Liver cirrhosis</topic><topic>Low flow</topic><topic>Lung diseases</topic><topic>Mechanical ventilation</topic><topic>Medical records</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>nosocomial infection</topic><topic>Nosocomial infections</topic><topic>Original</topic><topic>Oxygen</topic><topic>Oxygen therapy</topic><topic>Palivizumab</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Regression analysis</topic><topic>Respiratory diseases</topic><topic>Respiratory syncytial virus</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Ventilation</topic><topic>Ventilators</topic><topic>Virus diseases</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aikphaibul, Puneyavee</creatorcontrib><creatorcontrib>Theerawit, Tuangtip</creatorcontrib><creatorcontrib>Sophonphan, Jiratchaya</creatorcontrib><creatorcontrib>Wacharachaisurapol, Noppadol</creatorcontrib><creatorcontrib>Jitrungruengnij, Nattapong</creatorcontrib><creatorcontrib>Puthanakit, Thanyawee</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Influenza and other respiratory viruses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aikphaibul, Puneyavee</au><au>Theerawit, Tuangtip</au><au>Sophonphan, Jiratchaya</au><au>Wacharachaisurapol, Noppadol</au><au>Jitrungruengnij, Nattapong</au><au>Puthanakit, Thanyawee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand</atitle><jtitle>Influenza and other respiratory viruses</jtitle><addtitle>Influenza Other Respir Viruses</addtitle><date>2021-01</date><risdate>2021</risdate><volume>15</volume><issue>1</issue><spage>64</spage><epage>71</epage><pages>64-71</pages><issn>1750-2640</issn><eissn>1750-2659</eissn><abstract>Aim
To determine factors associated with severe hospitalized Respiratory syncytial virus (RSV)‐associated LRTI and to describe management in tertiary care center.
Methods
Retrospective medical record review was conducted among children under 5 years old hospitalized with RSV‐associated LRTI at King Chulalongkorn Memorial Hospital. Severe RSV‐associated LRTI was defined as death, mechanical ventilator, or positive pressure ventilation use, prolonged hospitalization >7 days. Factors associated with severe RSV were analyzed using univariate and multivariate logistic regression.
Results
From January 2011 to December 2016, 427 children were hospitalized. Median age was 10 months (IQR 4.2‐23.0). One hundred seventy‐four (41%) patients had severe RSV (11 deaths, 56 mechanical ventilators, 19 positive pressure ventilation, and 88 prolonged hospitalization). Factors associated with severe RSV were chronic lung disease (aOR 15.16 [4.26‐53.91]), cirrhosis/biliary atresia (aOR 15.01 [3.21‐70.32]), congenital heart disease (aOR 5.11 [1.97‐13.23]), chemotherapy (aOR 4.7 [1.34‐16.56]), and pre‐term (aOR 2.03 [1.13‐3.67]). Oxygen therapy was mainly low flow oxygen delivery. 88% of cases received bronchodilator. Parenteral antibiotics were prescribed in 37.9% of cases.
Conclusions
Children with co‐morbidities have higher risk of severe RSV‐associated LRTI. More than two‐third of patients received bronchodilator, of which was not recommended by American Academy of Pediatrics. The specific treatment and prevention for RSV are urgently needed.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>32783380</pmid><doi>10.1111/irv.12793</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5199-3749</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1750-2640 |
| ispartof | Influenza and other respiratory viruses, 2021-01, Vol.15 (1), p.64-71 |
| issn | 1750-2640 1750-2659 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7767956 |
| source | DOAJ Directory of Open Access Journals; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central |
| subjects | Antibiotics Antigens Biliary atresia bronchodilator Bronchodilators Cancer Cardiovascular disease Cardiovascular diseases Chemotherapy Children Cirrhosis community acquired Congenital diseases Congenital heart disease Convulsions & seizures Coronary artery disease death Developing countries Dyspnea Fever Genetic disorders Gestational age Health aspects Heart Heart diseases HIV Hospitalization Hospitals Human immunodeficiency virus Intubation Laboratories LDCs Liver cirrhosis Low flow Lung diseases Mechanical ventilation Medical records Morbidity Mortality nosocomial infection Nosocomial infections Original Oxygen Oxygen therapy Palivizumab Patients Pediatrics Regression analysis Respiratory diseases Respiratory syncytial virus Risk analysis Risk factors Ventilation Ventilators Virus diseases Viruses |
| title | Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T03%3A52%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20of%20severe%20hospitalized%20respiratory%20syncytial%20virus%20infection%20in%20tertiary%20care%20center%20in%20Thailand&rft.jtitle=Influenza%20and%20other%20respiratory%20viruses&rft.au=Aikphaibul,%20Puneyavee&rft.date=2021-01&rft.volume=15&rft.issue=1&rft.spage=64&rft.epage=71&rft.pages=64-71&rft.issn=1750-2640&rft.eissn=1750-2659&rft_id=info:doi/10.1111/irv.12793&rft_dat=%3Cgale_pubme%3EA711798055%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2472944539&rft_id=info:pmid/32783380&rft_galeid=A711798055&rfr_iscdi=true |